Product Name

  • Name

    Hydrocortisone

  • EINECS 200-020-1
  • CAS No. 50-23-7
  • Article Data65
  • CAS DataBase
  • Density 1.28 g/cm3
  • Solubility water: 100 mg/mL
  • Melting Point 211-214 °C(lit.)
  • Formula C21H30O5
  • Boiling Point 566.4 °C at 760 mmHg
  • Molecular Weight 362.466
  • Flash Point 310.4 °C
  • Transport Information
  • Appearance crystalline white powder
  • Safety 36/37-45-36-22
  • Risk Codes 63-62-40
  • Molecular Structure Molecular Structure of 50-23-7 (Hydrocortisone)
  • Hazard Symbols HarmfulXn
  • Synonyms Cortisol(8CI);11b,17,21-Trihydroxypregn-4-ene-3,20-dione;11b,17,21-Trihydroxyprogesterone;11b,17a,21-Trihydroxypregn-4-ene-3,20-dione;11b-Hydroxycortisone;17-Hydroxycorticosterone;4-Pregnene-11b,17a,21-triol-3,20-dione;Acticort;Aeroseb HC;Ala-Cort;Anflam;Anti-inflammatory hormone;CaldeCort Spray;Cetacort;Cobadex;Cortanal;Cortef;Corticreme;Cortiment;Cortispray;Cortril;Dermocortal;Dihydrocostisone;Domolene-HC;DuoCort;Efcorbin;Eldecort;Esiderm H;Evacort;
  • PSA 94.83000
  • LogP 1.78160

Synthetic route

hydrocortisone acetate
50-03-3

hydrocortisone acetate

HYDROCORTISONE
50-23-7

HYDROCORTISONE

Conditions
ConditionsYield
With potassium carbonate In methanol for 1h;95%
With sodium methylate In methanol at 20℃; for 0.5h;94.82%
With water; sodium hydroxide In tetrahydrofuran at 20℃; for 3h;91.3%
3,11β,17α,21-tetrahydroxypregn-4-en-20-one

3,11β,17α,21-tetrahydroxypregn-4-en-20-one

HYDROCORTISONE
50-23-7

HYDROCORTISONE

Conditions
ConditionsYield
With [(η5-C5Me5)Ir(6,6'-dihydroxy-2,2'-bipyridine)(H2O)]OTf2 In water; tert-butyl alcohol at 60℃; for 8h; chemoselective reaction;64%
Cortexolone
152-58-9

Cortexolone

A

HYDROCORTISONE
50-23-7

HYDROCORTISONE

B

Cortisone
53-06-5

Cortisone

C

Androstenedione
63-05-8

Androstenedione

Conditions
ConditionsYield
at 37℃; for 2h; 17,20-lyase, metyrapone, NAD+, malic acid;A n/a
B n/a
C 17%
With metyrapone; malic acid; 17,20-lyase; NAD at 37℃; for 2h; Product distribution; var. pH, temp., and cofactors;A n/a
B n/a
C 17%
Cortexolone
152-58-9

Cortexolone

HYDROCORTISONE
50-23-7

HYDROCORTISONE

Conditions
ConditionsYield
mit Hilfe von Cunninghamella blakesleeana;
mit Hilfe von Curvularia lunata;
With glucose-6-phosphate dehydrogenase; α-D-glucose 6-phosphate; adrenal mitochondrial 11-hydroxylase of squirrel monkey (Saimiri sciureus); 2-amino-2-hydroxymethyl-1,3-propanediol; NADPH; calcium chloride; magnesium chloride at 37℃; for 0.133333h; Product distribution; Kinetics; adrenal 11-hydroxylase of rhesus macaques and cynomolgus monkey, Km, Vmax, influence of metyrapone;
21-acetoxy-17-hydroxy-pregn-4-ene-3,11,20-trione-3,20-disemicarbazone
104117-71-7

21-acetoxy-17-hydroxy-pregn-4-ene-3,11,20-trione-3,20-disemicarbazone

HYDROCORTISONE
50-23-7

HYDROCORTISONE

Conditions
ConditionsYield
With potassium borohydride anschliessend mit HNO2;
3,3;20,20-bis-ethanediyldioxy-pregn-5-ene-11β,17,21-triol
76338-54-0

3,3;20,20-bis-ethanediyldioxy-pregn-5-ene-11β,17,21-triol

HYDROCORTISONE
50-23-7

HYDROCORTISONE

Conditions
ConditionsYield
With sulfuric acid
Progesterone
57-83-0

Progesterone

A

HYDROCORTISONE
50-23-7

HYDROCORTISONE

B

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

C

21-Hydroxyprogesterone
64-85-7

21-Hydroxyprogesterone

D

Corticosterone
50-22-6

Corticosterone

E

Cortexolone
152-58-9

Cortexolone

Conditions
ConditionsYield
With glucose-6-phosphate dehydrogenase; phosphate buffer; air; α-D-glucose 6-phosphate; midterm female fetal human adrenal tissue; NADP; magnesium chloride at 37℃; for 2h; Product distribution; <3H>labeled;A 36.3 % Chromat.
B n/a
C n/a
D 4.7 % Chromat.
E n/a
Progesterone
57-83-0

Progesterone

A

HYDROCORTISONE
50-23-7

HYDROCORTISONE

B

21-Hydroxyprogesterone
64-85-7

21-Hydroxyprogesterone

C

Corticosterone
50-22-6

Corticosterone

Conditions
ConditionsYield
With carbon dioxide; adenomatous adrenal tissue of patients with Cushing's syndrome; Krebs-Ringer bicarbonate solution; oxygen In ethanol at 37℃; for 1h; Product distribution; tritium labeled study;A 34.1 % Chromat.
B n/a
C 16.1 % Chromat.
Progesterone
57-83-0

Progesterone

A

HYDROCORTISONE
50-23-7

HYDROCORTISONE

B

Corticosterone
50-22-6

Corticosterone

Conditions
ConditionsYield
With carbon dioxide; Krebs-Ringer bicarbonate solution; normal adrenal tissue of patients with renal cell carcinoma; oxygen In ethanol at 37℃; for 1h; Product distribution; tritium labeled study;A 35.7 % Chromat.
B 40.6 % Chromat.
With carbon dioxide; Krebs-Ringer bicarbonate solution; surrounding adrenal tissue of patients with primary aldosteronism; oxygen In ethanol at 37℃; for 1h; Product distribution; tritium labeled study;A 16.7 % Chromat.
B 58.0 % Chromat.
17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

HYDROCORTISONE
50-23-7

HYDROCORTISONE

Conditions
ConditionsYield
With carbon dioxide; adenomatous and surrounding adrenal tissue of patients with Cushing's syndrome; Krebs-Ringer bicarbonate solution; primary aldosteronism or renal cell carcinoma; oxygen In ethanol at 37℃; for 1h; Product distribution; tritium labeled study;
17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

A

HYDROCORTISONE
50-23-7

HYDROCORTISONE

B

testosterone
58-22-0

testosterone

C

Androstenedione
63-05-8

Androstenedione

D

Cortexolone
152-58-9

Cortexolone

Conditions
ConditionsYield
With D-glucose 6-phosphate; sporadic adrenal pheochromocytomas; oxygen; NADP; glucose 6-phosphate dehydrogenase at 37℃; for 1h; Product distribution; <4-14C>-labeled;A 20.6 % Turnov.
B 1.1 % Turnov.
C 2.3 % Turnov.
D 14.8 % Turnov.
Cortexolone
152-58-9

Cortexolone

A

HYDROCORTISONE
50-23-7

HYDROCORTISONE

B

Cortisone
53-06-5

Cortisone

C

Epicortisol
566-35-8

Epicortisol

D

14,17,21-trihydroxy-pregn-4-ene-3,20-dione
595-18-6

14,17,21-trihydroxy-pregn-4-ene-3,20-dione

E

(8S,9S,10R,11S,13S,14S,17R)-17-((R)-1,2-dihydroxyethyl)-11,17-dihydroxy-10,13-dimethyl-6,7,8, 9,10,11,12,13,14,15,16, 17-dodecahydro-1H-cyclopenta[a] phenanthrene-3 (2H)-one
2899-95-8

(8S,9S,10R,11S,13S,14S,17R)-17-((R)-1,2-dihydroxyethyl)-11,17-dihydroxy-10,13-dimethyl-6,7,8, 9,10,11,12,13,14,15,16, 17-dodecahydro-1H-cyclopenta[a] phenanthrene-3 (2H)-one

Conditions
ConditionsYield
In ethanol Product distribution; culture of Cunningamella urvilaria lunata; also other cultures: C. blakesleeana, Th. hyalospora or Th. hiegemella orchidis were used; different times and temperatures of their preparation before reaction;A 52 % Chromat.
B 6 % Chromat.
C 4 % Chromat.
D 17 % Chromat.
E 1 % Chromat.
Epicortisol
566-35-8

Epicortisol

A

HYDROCORTISONE
50-23-7

HYDROCORTISONE

B

Cortisone
53-06-5

Cortisone

Conditions
ConditionsYield
In ethanol Product distribution; culture of Cunningamella urvilaria lunata; also other cultures: C. blakesleeana, Th. hyalospora or Th. hiegemella orchidis were used; different times and temperatures of their preparation before reaction;A 0.5 % Chromat.
B 0.5 % Chromat.
hydrocortisone hemisuccinate
2203-97-6

hydrocortisone hemisuccinate

HYDROCORTISONE
50-23-7

HYDROCORTISONE

Conditions
ConditionsYield
With tetramethyl ammoniumhydroxide; tetrazolium blue In ethanol Rate constant; Ambient temperature; reaction of corticosteroids and their hemisuccinate esters with blue tetrazolium under USP assay conditions, hydrolysis of esters, effect of water content, kinetic study by HPLC;
5'-(Cortisol-21-phosphoryl)-5-fluoro-2'-deoxyuridine ammonium salt

5'-(Cortisol-21-phosphoryl)-5-fluoro-2'-deoxyuridine ammonium salt

A

HYDROCORTISONE
50-23-7

HYDROCORTISONE

B

5-fluoro-2'-deoxyuridine-5'-O-monophosphate
134-46-3

5-fluoro-2'-deoxyuridine-5'-O-monophosphate

Conditions
ConditionsYield
With phosphodiesterase I (EC 3.1.4.1) Product distribution; further: 5'-nucleotidase (EC 3.1.3.5) from C. adamanteus, acid phosphatase (EC 3.1.3.2) from wheat germ;
hydrocortisone sodium succinate

hydrocortisone sodium succinate

A

HYDROCORTISONE
50-23-7

HYDROCORTISONE

B

Cortisone
53-06-5

Cortisone

C

(8S,9S,10R,11S,13S,14S)-11-Hydroxy-10,13-dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-2H-cyclopenta[a]phenanthrene-3,17-dione
382-44-5

(8S,9S,10R,11S,13S,14S)-11-Hydroxy-10,13-dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-2H-cyclopenta[a]phenanthrene-3,17-dione

D

cortisone sodium succinate

cortisone sodium succinate

Conditions
ConditionsYield
Product distribution; Rate constant; Irradiation; multistep reaction, radiolytic degradation;
3-(4-Methyl-piperazin-1-ylmethyl)-benzoic acid 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl ester

3-(4-Methyl-piperazin-1-ylmethyl)-benzoic acid 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl ester

A

HYDROCORTISONE
50-23-7

HYDROCORTISONE

B

3-[(4-methylpiperazin-1-yl)methyl]benzoic acid
514209-42-8

3-[(4-methylpiperazin-1-yl)methyl]benzoic acid

Conditions
ConditionsYield
In water at 37℃; phosphate buffer pH=7.4, human plasma; other N-subst. (aminomethyl)benzoate esters of drugs; variation of the pH; other temperature;
(S)-2,6-Diamino-hexanoic acid 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl ester; hydrochloride

(S)-2,6-Diamino-hexanoic acid 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl ester; hydrochloride

A

HYDROCORTISONE
50-23-7

HYDROCORTISONE

B

L-lysine
56-87-1

L-lysine

C

(S)-2,6-Diamino-hexanoic acid (8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxy-acetyl)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl ester; hydrochloride

(S)-2,6-Diamino-hexanoic acid (8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxy-acetyl)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl ester; hydrochloride

Conditions
ConditionsYield
With actate buffer In water at 25℃; Rate constant; rate constante for the hydrolysis and acyl migration; pH 5; other pH;
Conditions
ConditionsYield
β-glucoronidase I In water at 37℃; for 0.166667h; Product distribution; substrate specifity of enzyme;
β-glucoronidase II In water at 37℃; for 0.166667h; Product distribution; substrate specifity of enzyme;
Hydrocortisone pivalate

Hydrocortisone pivalate

HYDROCORTISONE
50-23-7

HYDROCORTISONE

Conditions
ConditionsYield
With Curvularia lunata In water at 30℃; for 65h; Yield given;
11β,17,21-trihydroxy-16-tritio-pregn-4-ene-3,20-dione

11β,17,21-trihydroxy-16-tritio-pregn-4-ene-3,20-dione

HYDROCORTISONE
50-23-7

HYDROCORTISONE

Conditions
ConditionsYield
Herstellung;
17,21-dihydroxy-pregn-4-ene-3,11,20-trione-3,20-disemicarbazone

17,21-dihydroxy-pregn-4-ene-3,11,20-trione-3,20-disemicarbazone

HYDROCORTISONE
50-23-7

HYDROCORTISONE

Conditions
ConditionsYield
With lithium borohydride anschliessend mit Brenztraubensaeure;
Pregnenolone
145-13-1

Pregnenolone

A

HYDROCORTISONE
50-23-7

HYDROCORTISONE

B

testosterone
58-22-0

testosterone

C

Androstenedione
63-05-8

Androstenedione

D

21-Hydroxyprogesterone
64-85-7

21-Hydroxyprogesterone

E

Corticosterone
50-22-6

Corticosterone

F

Cortexolone
152-58-9

Cortexolone

G

DHEA

DHEA

Conditions
ConditionsYield
With D-glucose 6-phosphate; sporadic adrenal pheochromocytomas; oxygen; NADP; glucose 6-phosphate dehydrogenase at 37℃; for 1h; Product distribution; <4-14C>-labeled;A 12.6 % Turnov.
B 0.9 % Turnov.
C 1.9 % Turnov.
D 2.4 % Turnov.
E 6.8 % Turnov.
F 2.3 % Turnov.
G n/a
Cortisone acetate
50-04-4

Cortisone acetate

HYDROCORTISONE
50-23-7

HYDROCORTISONE

Conditions
ConditionsYield
Multi-step reaction with 2 steps
2: KBH4 / anschliessend mit HNO2
View Scheme
22-acetoxy-11β-hydroxy-3-oxo-23,24-dinor-5β-chol-17(20)ξ-ene-21-nitrile
102213-14-9

22-acetoxy-11β-hydroxy-3-oxo-23,24-dinor-5β-chol-17(20)ξ-ene-21-nitrile

HYDROCORTISONE
50-23-7

HYDROCORTISONE

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: OsO4
2: bromine / dann mit Semicarbazid und anschliessend mit Brenztraubensaeure
3: KHCO3
View Scheme
RU 18760
64313-94-6

RU 18760

HYDROCORTISONE
50-23-7

HYDROCORTISONE

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: bromine / dann mit Semicarbazid und anschliessend mit Brenztraubensaeure
2: KHCO3
View Scheme
Epicortisol
566-35-8

Epicortisol

HYDROCORTISONE
50-23-7

HYDROCORTISONE

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: benzene; toluene-4-sulfonic acid
2: chromium (VI)-oxide; pyridine
3: sodium borate; aq. NaOH solution
4: aqueous H2SO4
View Scheme
3,3;20,20-bis-ethanediyldioxy-17,21-dihydroxy-pregn-5-en-11-one
101524-47-4

3,3;20,20-bis-ethanediyldioxy-17,21-dihydroxy-pregn-5-en-11-one

HYDROCORTISONE
50-23-7

HYDROCORTISONE

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: tetrahydrofuran; lithium alanate; diethyl ether
2: aqueous H2SO4
View Scheme
Multi-step reaction with 2 steps
1: sodium borate; aq. NaOH solution
2: aqueous H2SO4
View Scheme
3,20-bis(ethylenedioxy)-11α,17α,21-trihydroxypregn-5-ene
102030-55-7

3,20-bis(ethylenedioxy)-11α,17α,21-trihydroxypregn-5-ene

HYDROCORTISONE
50-23-7

HYDROCORTISONE

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: chromium (VI)-oxide; pyridine
2: sodium borate; aq. NaOH solution
3: aqueous H2SO4
View Scheme
HYDROCORTISONE
50-23-7

HYDROCORTISONE

(8S,9S,10R,11S,13S,14S)-11-Hydroxy-10,13-dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-2H-cyclopenta[a]phenanthrene-3,17-dione
382-44-5

(8S,9S,10R,11S,13S,14S)-11-Hydroxy-10,13-dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-2H-cyclopenta[a]phenanthrene-3,17-dione

Conditions
ConditionsYield
Stage #1: HYDROCORTISONE With sodium tetrahydroborate In ethanol; dichloromethane for 2h;
Stage #2: With sodium periodate In acetone at 20℃;
100%
In water; acetonitrile at 20℃; Electrochemical reaction;99%
Stage #1: HYDROCORTISONE With sodium tetrahydroborate In ethanol; dichloromethane at 20℃; for 2h;
Stage #2: With sodium periodate In ethanol; dichloromethane; water; acetone at 20℃;
99%
HYDROCORTISONE
50-23-7

HYDROCORTISONE

acetic anhydride
108-24-7

acetic anhydride

hydrocortisone acetate
50-03-3

hydrocortisone acetate

Conditions
ConditionsYield
With pyridine at 20℃;100%
With pyridine at 0 - 25℃; for 24h;99%
With pyridine at 0 - 20℃;91%
HYDROCORTISONE
50-23-7

HYDROCORTISONE

diethyl dicarbonate
1609-47-8

diethyl dicarbonate

Hydrocortisone-21-ethyl carbonate

Hydrocortisone-21-ethyl carbonate

Conditions
ConditionsYield
In ethanol for 0.5h; Heating;100%
HYDROCORTISONE
50-23-7

HYDROCORTISONE

5β-pregnane-11β,17α,21-triol-3,20-dione
1482-50-4

5β-pregnane-11β,17α,21-triol-3,20-dione

Conditions
ConditionsYield
With palladium 10% on activated carbon; hydrogen In N,N-dimethyl-formamide at 30℃; under 2585.81 Torr;100%
With hydrogen; palladium 10% on activated carbon In N,N-dimethyl-formamide at 25 - 35℃; under 3102.97 Torr; for 6h;91.5%
With palladium 10% on activated carbon; hydrogen In N,N-dimethyl-formamide at 25 - 35℃; under 3102.97 Torr; for 6h; Autoclave;91.5%
HYDROCORTISONE
50-23-7

HYDROCORTISONE

orthoformic acid triethyl ester
122-51-0

orthoformic acid triethyl ester

C23H32O4

C23H32O4

Conditions
ConditionsYield
With toluene-4-sulfonic acid In ethanol at 40 - 45℃; Reagent/catalyst; Solvent;99.2%
succinic acid anhydride
108-30-5

succinic acid anhydride

HYDROCORTISONE
50-23-7

HYDROCORTISONE

hydrocortisone hemisuccinate
2203-97-6

hydrocortisone hemisuccinate

Conditions
ConditionsYield
With pyridine at 20℃; for 24h;98%
With pyridine for 5h; Heating;94%
Stage #1: succinic acid anhydride; HYDROCORTISONE With dmap In tetrahydrofuran; N,N-dimethyl-formamide at 45℃; for 4h;
Stage #2: In tetrahydrofuran; N,N-dimethyl-formamide; acetone at 0 - 10℃; for 2h;
89%
HYDROCORTISONE
50-23-7

HYDROCORTISONE

prednisolon
50-24-8

prednisolon

Conditions
ConditionsYield
With Rhodococcus coprophilus DSM 43347 In dimethyl sulfoxide at 30℃; for 24h; Reagent/catalyst; Green chemistry; regiospecific reaction;97%
With 2,3-dicyano-5,6-dichloro-p-benzoquinone In 1,4-dioxane for 4h; Reflux;83.33%
With potassium phosphate buffer In methanol at 30℃; free and the urethane prepolymer-entrapped acetone-dried cells of Arthrobacter simplex; effect of gel hydrophobicity; effect of electron acceptors and solvents;
With 3-ketosteroid-Δ1-dehydrogenase from Mycobacterium smegmatis mc2155; phenazine methosulfate In dimethyl sulfoxide at 30℃; for 16h; pH=8; Catalytic behavior; Kinetics; Solvent; Reagent/catalyst; Enzymatic reaction;
succinic acid anhydride
108-30-5

succinic acid anhydride

HYDROCORTISONE
50-23-7

HYDROCORTISONE

hydrocortisone-succinate-hydrocortisone

hydrocortisone-succinate-hydrocortisone

Conditions
ConditionsYield
With pyridine for 4h; Heating;97%
HYDROCORTISONE
50-23-7

HYDROCORTISONE

21-dehydrohydrocortisone dimer

21-dehydrohydrocortisone dimer

Conditions
ConditionsYield
With air; copper diacetate In methanol for 5h;97%
succinic acid anhydride
108-30-5

succinic acid anhydride

HYDROCORTISONE
50-23-7

HYDROCORTISONE

hydrocortisone sodium succinate

hydrocortisone sodium succinate

Conditions
ConditionsYield
Stage #1: succinic acid anhydride; HYDROCORTISONE With dmap In tetrahydrofuran; N,N-dimethyl-formamide at 45℃; for 4h;
Stage #2: In tetrahydrofuran; N,N-dimethyl-formamide; acetone at 0 - 10℃; for 2h;
Stage #3: With sodium hydrogencarbonate In water; acetone at 15 - 25℃; for 3h; Temperature;
97%
HYDROCORTISONE
50-23-7

HYDROCORTISONE

cortienic acid
3597-45-3

cortienic acid

Conditions
ConditionsYield
In tetrahydrofuran; methanol; water96%
In tetrahydrofuran; methanol; water96%
With periodic acid In tetrahydrofuran at 20℃; for 2h;95%
formaldehyd
50-00-0

formaldehyd

HYDROCORTISONE
50-23-7

HYDROCORTISONE

6-methine hydrocortisone

6-methine hydrocortisone

Conditions
ConditionsYield
Stage #1: HYDROCORTISONE With Pyridine hydrobromide; Triethyl orthoacetate In ethanol at 20℃; for 0.166667h;
Stage #2: formaldehyd With N-methylaniline In ethanol; water at 20℃; for 3h; Reagent/catalyst;
95.7%
HYDROCORTISONE
50-23-7

HYDROCORTISONE

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

21-tert-butyldimethylsilyloxy-11β,17-dihydroxypregn-4-ene-3,20-dione
146201-53-8

21-tert-butyldimethylsilyloxy-11β,17-dihydroxypregn-4-ene-3,20-dione

Conditions
ConditionsYield
With 1H-imidazole In N,N-dimethyl-formamide for 0.25h;95%
succinic acid anhydride
108-30-5

succinic acid anhydride

HYDROCORTISONE
50-23-7

HYDROCORTISONE

21-(3-Carboxy-1-oxopropoxy)-17α-hydroxy-11α-hydroxypregna-4-ene-3,20-dione
103242-89-3

21-(3-Carboxy-1-oxopropoxy)-17α-hydroxy-11α-hydroxypregna-4-ene-3,20-dione

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In diethyl ether; ethyl acetate; acetonitrile95%
HYDROCORTISONE
50-23-7

HYDROCORTISONE

methanesulfonyl chloride
124-63-0

methanesulfonyl chloride

(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-10,13-dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydrospiro[cyclopenta[a]phenanthrene-17,2′-oxetane]-3,3′(2H)-dione
77826-00-7

(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-10,13-dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydrospiro[cyclopenta[a]phenanthrene-17,2′-oxetane]-3,3′(2H)-dione

Conditions
ConditionsYield
Stage #1: HYDROCORTISONE; methanesulfonyl chloride With pyridine In water at 0℃; for 2h;
Stage #2: With potassium tert-butylate In tetrahydrofuran at 20℃; for 0.5h;
95%
HYDROCORTISONE
50-23-7

HYDROCORTISONE

methanesulfonyl chloride
124-63-0

methanesulfonyl chloride

11β,7α-dihydroxy-21-<(methylsulfonyl)oxy>pregn-4-ene-3,20-dione
6677-96-9

11β,7α-dihydroxy-21-<(methylsulfonyl)oxy>pregn-4-ene-3,20-dione

Conditions
ConditionsYield
With pyridine at 0℃; for 0.25h;94%
With N-ethyl-N,N-diisopropylamine In dichloromethane at 0 - 20℃;92%
Stage #1: HYDROCORTISONE With N-ethyl-N,N-diisopropylamine In dichloromethane at 0℃; for 0.0833333h;
Stage #2: methanesulfonyl chloride In dichloromethane at 0℃; for 4 - 6h;
82%
HYDROCORTISONE
50-23-7

HYDROCORTISONE

Corticosterone
50-22-6

Corticosterone

Conditions
ConditionsYield
With trimethylsilyl iodide In acetonitrile at 20℃; for 0.333333h;94%
With trimethylsilyl iodide In acetonitrile at 20℃; for 0.333333h;94%
With trimethylsilyl iodide In acetonitrile for 3h; Ambient temperature;71%
With trimethylsilyl iodide In acetonitrile for 3h; Ambient temperature;71%
With trimethylsilyl iodide In acetonitrile at 20℃; for 3h;45%
HYDROCORTISONE
50-23-7

HYDROCORTISONE

hexanoic acid
142-62-1

hexanoic acid

21-hexanoyloxy-11β,17α-dihydroxypregn-4-en-3,20-dione
3593-96-2

21-hexanoyloxy-11β,17α-dihydroxypregn-4-en-3,20-dione

Conditions
ConditionsYield
With Candida antarctica lipase B In ethanol; toluene at 110℃; regioselective reaction;93%
HYDROCORTISONE
50-23-7

HYDROCORTISONE

acetic acid methyl ester
79-20-9

acetic acid methyl ester

hydrocortisone acetate
50-03-3

hydrocortisone acetate

Conditions
ConditionsYield
With Candida antarctica lipase B In ethyl acetate at 55℃; regioselective reaction;92%
HYDROCORTISONE
50-23-7

HYDROCORTISONE

Octanoic acid
124-07-2

Octanoic acid

21-octanoyloxy-11β,17α-dihydroxypregn-4-en-3,20-dione

21-octanoyloxy-11β,17α-dihydroxypregn-4-en-3,20-dione

Conditions
ConditionsYield
With Candida antarctica lipase B In ethanol; toluene at 110℃; regioselective reaction;92%
HYDROCORTISONE
50-23-7

HYDROCORTISONE

adrenosterone
382-45-6

adrenosterone

Conditions
ConditionsYield
With dipyridinium dichromate In dichloromethane for 44h; Ambient temperature;91%
With chromium(VI) oxide In acetic acid at 20℃; for 4h; other oxid. reagents;73%
Multi-step reaction with 2 steps
1: aqueous periodic acid
2: CrO3; acetic acid
View Scheme
Multi-step reaction with 2 steps
1.1: sodium tetrahydroborate / dichloromethane; ethanol / 2 h
1.2: 20 °C
2.1: chromium(VI) oxide / water; acetic acid / 1.5 h
View Scheme
Multi-step reaction with 2 steps
1: acetonitrile; water / 20 °C / Electrochemical reaction
2: 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; sodium carbonate / acetonitrile; water / Electrochemical reaction
View Scheme
HYDROCORTISONE
50-23-7

HYDROCORTISONE

C14H19NO4
1070955-54-2

C14H19NO4

3-(2-t-butoxycarbonylaminophenyl)propionic acid 2-(11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl ester
1154703-35-1

3-(2-t-butoxycarbonylaminophenyl)propionic acid 2-(11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl ester

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane91%
HYDROCORTISONE
50-23-7

HYDROCORTISONE

methyl hexanoate
106-70-7

methyl hexanoate

21-hexanoyloxy-11β,17α-dihydroxypregn-4-en-3,20-dione
3593-96-2

21-hexanoyloxy-11β,17α-dihydroxypregn-4-en-3,20-dione

Conditions
ConditionsYield
With Candida antarctica lipase B In toluene at 110℃; regioselective reaction;90%
HYDROCORTISONE
50-23-7

HYDROCORTISONE

methyl octanate
111-11-5

methyl octanate

21-octanoyloxy-11β,17α-dihydroxypregn-4-en-3,20-dione

21-octanoyloxy-11β,17α-dihydroxypregn-4-en-3,20-dione

Conditions
ConditionsYield
With Candida antarctica lipase B In toluene at 110℃; regioselective reaction;90%
HYDROCORTISONE
50-23-7

HYDROCORTISONE

1-allyl-1-isopropoxysiletane

1-allyl-1-isopropoxysiletane

(8S,9S,10R,11S,13S,14S,17R)-17-(1,2-dihydroxypent-4-en-2-yl)-11,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one

(8S,9S,10R,11S,13S,14S,17R)-17-(1,2-dihydroxypent-4-en-2-yl)-11,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one

Conditions
ConditionsYield
In acetonitrile at 80℃; for 8h; Schlenk technique; Inert atmosphere;90%
HYDROCORTISONE
50-23-7

HYDROCORTISONE

methacrylic anhydride

methacrylic anhydride

cortisol 21-monomethacrylate

cortisol 21-monomethacrylate

Conditions
ConditionsYield
With dmap; triethylamine In tetrahydrofuran at 0 - 20℃; for 48h; Inert atmosphere;89%
HYDROCORTISONE
50-23-7

HYDROCORTISONE

4-bromocortisol

4-bromocortisol

Conditions
ConditionsYield
With oxone; triethylamine; sodium bromide In tetrahydrofuran; water at 20℃; for 3h;89%
HYDROCORTISONE
50-23-7

HYDROCORTISONE

acetic anhydride
108-24-7

acetic anhydride

A

3,11β,17α,21-tetraacetoxy-3,5-pregnadiene-20-one
991-08-2

3,11β,17α,21-tetraacetoxy-3,5-pregnadiene-20-one

B

11β,17α,21-triacetoxy-pregn-4-ene-3,20-dione
3517-51-9

11β,17α,21-triacetoxy-pregn-4-ene-3,20-dione

Conditions
ConditionsYield
With toluene-4-sulfonic acid for 0.0833333h; microwave irradiation;A 88%
B n/a

Hydrocortisone Consensus Reports

Reported in EPA TSCA Inventory.

Hydrocortisone Specification

1. Introduction of Hydrocortisone
Hydrocortisone is one kind of crystalline white powder. The IUPAC Name of this chemical is (8S,9S,10R,11S,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one. In addition, the Classification Code of this chemical is Anti-Inflammatory Agents; Drug / Therapeutic Agent; Glucocorticoid; Mutation data; Reproductive Effect. Hydrocortisone is very slightly soluble in water and sparingly soluble in alcohol.

2. Properties of Hydrocortisone
Physical properties about Hydrocortisone are:
(1)Melting point: 211-214 °C(lit.); (2)Storage temp.: -20°C; (3)Solubility: H2O: 100 mg/mL; (4)Index of Refraction: 1.594; (5)Molar Refractivity: 95.57 cm3; (6)Molar Volume: 281.3 cm3; (7)Surface Tension: 58.8 dyne/cm; (8)Density: 1.28 g/cm3; (9)Flash Point: 310.4 °C; (10)Enthalpy of Vaporization: 97.71 kJ/mol; (11)Boiling Point: 566.4 °C at 760 mmHg; (12)Vapour Pressure: 3.44E-15 mmHg at 25 °C; (13)XLogP3-AA: 1.6; (14)H-Bond Donor: 3; (15)H-Bond Acceptor: 5.

3. Structure Descriptors of Hydrocortisone
(1)Canonical SMILES: CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
(2)Isomeric SMILES: C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O
(3)InChI: InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1 
(4)InChIKey: JYGXADMDTFJGBT-VWUMJDOOSA-N

4. Toxicity of Hydrocortisone

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
man TDLo oral 400mg/kg/10D- (400mg/kg) BEHAVIORAL: CHANGES IN PSYCHOPHYSIOLOGICAL TESTS Psychopharmacology Vol. 145, Pg. 260, 1999.
mouse LD50 subcutaneous > 500mg/kg (500mg/kg)   Khimiko-Farmatsevticheskii Zhurnal. Chemical Pharmaceutical Journal. For English translation, see PCJOAU. Vol. 24(3), Pg. 26, 1990.
rat LD50 intraperitoneal 150mg/kg (150mg/kg)   Japanese Journal of Pharmacology. Vol. 21, Pg. 377, 1971.
rat LD50 subcutaneous 449mg/kg (449mg/kg)   Toxicology and Applied Pharmacology. Vol. 8, Pg. 250, 1966.

5. Safety information of Hydrocortisone
Poison by intraperitoneal route. Moderately toxic by subcutaneous route. An experimental teratogen. Other experimental reproductive effects. Mutation data reported. A steroid. When heated to decomposition it emits very toxic fumes of SOx and NOx.
Hazard Codes: XnHarmful
WGK Germany: 3
Risk Statements: 63-62-40 
R62: Risk of impaired fertility. 
R63: Possible risk of harm to the unborn child. 
R40: Limited evidence of a carcinogenic effect.
Safety Statements of Hydrocortisone: 36/37-45-36-22 
S36/37: Wear suitable protective clothing and gloves. 
S45: In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) 
S36: Wear suitable protective clothing. 
S22: Do not breathe dust.

6. Uses of Hydrocortisone
Hydrocortisone (CAS NO.50-23-7) is used to treat a variety of different illnesses. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions.

7. Production of Hydrocortisone
Hydrocortisone can be got from the adrenal gland. Or it can be got from 17α- hydroxyprogesterone.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View